Literature DB >> 22451117

Hypovitaminosis D in adults with inflammatory bowel disease: potential role of ethnicity.

Yi-Tzu Nancy Fu1, Nazira Chatur, Cindy Cheong-Lee, Baljinder Salh.   

Abstract

BACKGROUND: Although vitamin D deficiency occurs in inflammatory bowel disease (IBD), it is currently unclear to what extent ethnicity affects vitamin D levels. Our aim was therefore to determine the ethnic variation in serum 25-hydroxyvitamin D status and its association with disease severity in adults with IBD.
METHODS: We conducted a prospective cohort study in ambulatory care IBD patients. Clinical disease severity was assessed through validated questionnaires. Serum 25-hydroxyvitamin D levels were used for vitamin D status. C-reactive protein (CRP), ferritin and hemoglobin (Hgb) levels were correlated with serum 25-hydroxyvitamin D levels.
RESULTS: Sixty ulcerative colitis (UC) and forty Crohn's disease (CD) patients were enrolled comprising 65 % Caucasians and 29 % South Asians. However, South Asians had consistently lower average serum 25-hydroxyvitamin D levels (All 44.8 ± 18.1 nmol/L, UC 48.2 ± 18.3 nmol/L, CD 24.3 ± 13.3 nmol/L). Hypovitaminosis D was found in 39 % of All, 36.7 % of UC and 42.5 % of CD patients. A significantly higher proportion of South Asians were vitamin D deficient when compared to Caucasians in All and CD groups (58.6 % vs. 30.8 %, p = 0.01 and 85.7 % vs. 32.3 %, p < 0.01, respectively).
CONCLUSIONS: A significantly higher percentage of South Asians had hypovitaminosis D when compared to Caucasians. Disease severity trended towards an inverse relationship with vitamin D status in all South Asian and Caucasian CD patients, although most patients in this study had only mild to moderate disease. We suggest that vitamin D supplementation should be considered in all adult IBD patients.

Entities:  

Mesh:

Year:  2012        PMID: 22451117     DOI: 10.1007/s10620-012-2130-7

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN: 0163-2116            Impact factor:   3.199


  34 in total

1.  Bone mineral density, vitamin D, and disease activity in children newly diagnosed with inflammatory bowel disease.

Authors:  Wael El-Matary; Sheena Sikora; Donald Spady
Journal:  Dig Dis Sci       Date:  2010-08-20       Impact factor: 3.199

2.  Toll-like receptor triggering of a vitamin D-mediated human antimicrobial response.

Authors:  Philip T Liu; Steffen Stenger; Huiying Li; Linda Wenzel; Belinda H Tan; Stephan R Krutzik; Maria Teresa Ochoa; Jürgen Schauber; Kent Wu; Christoph Meinken; Diane L Kamen; Manfred Wagner; Robert Bals; Andreas Steinmeyer; Ulrich Zügel; Richard L Gallo; David Eisenberg; Martin Hewison; Bruce W Hollis; John S Adams; Barry R Bloom; Robert L Modlin
Journal:  Science       Date:  2006-02-23       Impact factor: 47.728

Review 3.  Vitamin D deficiency.

Authors:  Michael F Holick
Journal:  N Engl J Med       Date:  2007-07-19       Impact factor: 91.245

4.  25 (OH) vitamin D level in Crohn's disease: association with sun exposure & disease activity.

Authors:  A J Joseph; Biju George; A B Pulimood; M S Seshadri; Ashok Chacko
Journal:  Indian J Med Res       Date:  2009-08       Impact factor: 2.375

Review 5.  Genetics and pathogenesis of inflammatory bowel disease.

Authors:  Bernard Khor; Agnès Gardet; Ramnik J Xavier
Journal:  Nature       Date:  2011-06-15       Impact factor: 49.962

6.  Vitamin D deficiency in mice impairs colonic antibacterial activity and predisposes to colitis.

Authors:  Venu Lagishetty; Alexander V Misharin; Nancy Q Liu; Thomas S Lisse; Rene F Chun; Yi Ouyang; Sandra M McLachlan; John S Adams; Martin Hewison
Journal:  Endocrinology       Date:  2010-04-14       Impact factor: 4.736

7.  Novel role of the vitamin D receptor in maintaining the integrity of the intestinal mucosal barrier.

Authors:  Juan Kong; Zhongyi Zhang; Mark W Musch; Gang Ning; Jun Sun; John Hart; Marc Bissonnette; Yan Chun Li
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2007-10-25       Impact factor: 4.052

8.  The effect of a fortified milk drink on vitamin D status and bone turnover in post-menopausal women from South East Asia.

Authors:  Marlena C Kruger; Linda M Schollum; Barbara Kuhn-Sherlock; Andon Hestiantoro; Paulus Wijanto; Julie Li-Yu; Imelda Agdeppa; Joanne M Todd; Richard Eastell
Journal:  Bone       Date:  2009-11-04       Impact factor: 4.398

9.  Clinical trial: vitamin D3 treatment in Crohn's disease - a randomized double-blind placebo-controlled study.

Authors:  S P Jørgensen; J Agnholt; H Glerup; S Lyhne; G E Villadsen; C L Hvas; L E Bartels; J Kelsen; L A Christensen; J F Dahlerup
Journal:  Aliment Pharmacol Ther       Date:  2010-05-11       Impact factor: 8.171

10.  Vitamin D status and its association with parathyroid hormone concentrations in women of child-bearing age living in Jakarta and Kuala Lumpur.

Authors:  T J Green; C M Skeaff; J E P Rockell; B J Venn; A Lambert; J Todd; G L Khor; S P Loh; S Muslimatun; R Agustina; S J Whiting
Journal:  Eur J Clin Nutr       Date:  2007-03-07       Impact factor: 4.016

View more
  26 in total

Review 1.  Linking vitamin d deficiency to inflammatory bowel disease.

Authors:  Matthew T Palmer; Casey T Weaver
Journal:  Inflamm Bowel Dis       Date:  2013-09       Impact factor: 5.325

2.  Vitamin D deficiency and corticosteroid use are risk factors for low bone mineral density in inflammatory bowel disease patients.

Authors:  Bincy P Abraham; Preethi Prasad; Hoda M Malaty
Journal:  Dig Dis Sci       Date:  2014-03-12       Impact factor: 3.199

3.  Factors associated with vitamin D deficiency in a multicultural inflammatory bowel disease cohort.

Authors:  Sukhdev Chatu; Vivek Chhaya; Rosamund Holmes; Penny Neild; Jin-Yong Kang; Richard C Pollok; Andrew Poullis
Journal:  Frontline Gastroenterol       Date:  2012-10-31

4.  Association of Vitamin D Level With Clinical Status in Inflammatory Bowel Disease: A 5-Year Longitudinal Study.

Authors:  Toufic A Kabbani; Ioannis E Koutroubakis; Robert E Schoen; Claudia Ramos-Rivers; Nilesh Shah; Jason Swoger; Miguel Regueiro; Arthur Barrie; Marc Schwartz; Jana G Hashash; Leonard Baidoo; Michael A Dunn; David G Binion
Journal:  Am J Gastroenterol       Date:  2016-03-08       Impact factor: 10.864

Review 5.  Vitamin D improves inflammatory bowel disease outcomes: basic science and clinical review.

Authors:  Krista M Reich; Richard N Fedorak; Karen Madsen; Karen I Kroeker
Journal:  World J Gastroenterol       Date:  2014-05-07       Impact factor: 5.742

Review 6.  Review article: vitamin D and inflammatory bowel diseases.

Authors:  V P Mouli; A N Ananthakrishnan
Journal:  Aliment Pharmacol Ther       Date:  2013-11-17       Impact factor: 8.171

7.  Serum 25-hydroxyvitamin D concentration is inversely associated with mucosal inflammation in patients with ulcerative colitis.

Authors:  Katherine Meckel; Yan Chun Li; John Lim; Masha Kocherginsky; Chris Weber; Anas Almoghrabi; Xindi Chen; Austin Kaboff; Farhana Sadiq; Stephen B Hanauer; Russell D Cohen; John Kwon; David T Rubin; Ira Hanan; Atsushi Sakuraba; Eugene Yen; Marc Bissonnette; Joel Pekow
Journal:  Am J Clin Nutr       Date:  2016-06-08       Impact factor: 7.045

8.  Influence of Severe Vitamin D Deficiency on the Clinical Course of Inflammatory Bowel Disease.

Authors:  Nam Seok Ham; Sung Wook Hwang; Eun Hye Oh; Jeongseok Kim; Ho-Su Lee; Sang Hyoung Park; Dong-Hoon Yang; Byong Duk Ye; Jeong-Sik Byeon; Seung-Jae Myung; Suk-Kyun Yang
Journal:  Dig Dis Sci       Date:  2020-03-26       Impact factor: 3.199

9.  Vitamin D Deficiency in a Portuguese Cohort of Patients with Inflammatory Bowel Disease: Prevalence and Relation to Disease Activity.

Authors:  Joana C Branco; Mariana F Cardoso; Vera Anapaz; Luís Carvalho Lourenço; Ana Maria Oliveira; Catarina Graça Rodrigues; Liliana Santos; Jorge A Reis
Journal:  GE Port J Gastroenterol       Date:  2018-05-14

10.  Is there a relation between vitamin D, interleukin-17, and bone mineral density in patients with inflammatory bowel disease?

Authors:  Iwona Krela-Kazmierczak; Aleksandra Szymczak-Tomczak; Maciej Tomczak; Liliana Lykowska-Szuber; Piotr Eder; Marcin A Kucharski; Kamila Stawczyk-Eder; Katarzyna Waszak; Jacek Karczewski; Agnieszka Dobrowolska
Journal:  Arch Med Sci       Date:  2018-09-05       Impact factor: 3.318

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.